Document Detail


When choosing statin therapy: the case for generics.
MedLine Citation:
PMID:  23303273     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The development of "Top 5" lists across specialties and at regular intervals can help to remind physicians that optimal care is often possible at a lower cost. For purposes of cardiovascular risk reduction, generic statins, or their brand equivalents if priced similarly, remain the appropriate choice for dyslipidemic patients initiating statin therapy. In this article, we review the evidence supporting the choice of generic statins.
Authors:
Jonas B Green; Joseph S Ross; Cynthia A Jackevicius; Nilay D Shah; Harlan M Krumholz
Related Documents :
17015563 - Rethinking well-child care in the united states: an international comparison.
20331663 - Placement in foster care enhances quality of attachment among young institutionalized c...
10090523 - Clinical audit and the contribution of the laboratory to clinical outcome.
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  JAMA internal medicine     Volume:  173     ISSN:  2168-6114     ISO Abbreviation:  JAMA Intern Med     Publication Date:  2013 Feb 
Date Detail:
Created Date:  2013-02-12     Completed Date:  2013-04-08     Revised Date:  2013-10-22    
Medline Journal Info:
Nlm Unique ID:  101589534     Medline TA:  JAMA Intern Med     Country:  United States    
Other Details:
Languages:  eng     Pagination:  229-32     Citation Subset:  AIM; IM    
Affiliation:
Cedars-Sinai Medicine, Department of Medicine, Cedars-Sinai Health System, Los Angeles, CA 90049, USA. Jonas.Green@cshs.org
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Cardiovascular Diseases / etiology,  prevention & control*
Choice Behavior
Drugs, Generic*
Dyslipidemias / complications
Evidence-Based Medicine
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors / economics,  pharmacokinetics,  therapeutic use*
Therapeutic Equivalency
Chemical
Reg. No./Substance:
0/Drugs, Generic; 0/Hydroxymethylglutaryl-CoA Reductase Inhibitors
Comments/Corrections
Comment In:
JAMA Intern Med. 2013 Aug 12;173(15):1473-4   [PMID:  23939520 ]
JAMA Intern Med. 2013 Aug 12;173(15):1474   [PMID:  23939523 ]
JAMA Intern Med. 2013 Feb 11;173(3):233-4   [PMID:  23303368 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Rapid correction rate of hyponatremia as an independent risk factor for neurological complication fo...
Next Document:  Highly efficient and chemoselective ?-iodination of acrylate esters through Morita-Baylis-Hillman-ty...